Table 2 Treatment, diabetes’ complications and comorbidities of patients with diabetic mellitus and diabetic foot ulcers (Group D).
Treatment | N (%) | Diabetes’ complications and comorbidities | N (%) | Ulcer | N (%) |
|---|---|---|---|---|---|
Insulin and hypoglycaemia oral agents/GLP1 agonist injection | 21 (91,3) | Neuropathy | 3 (13,0) | Previous ulcer in another location | 6 (26,1) |
Hypoglycemic oral agents/ GLP1 agonist injection only | 1 (4,3) | Chronic kidney disease | 1 (4,3) | Previous amputation in another location | 4 (17,4) |
Only by diet | 1 (4,3) | Retinopathy | 2 (8,7) | Previous HBO due to the ulcer in another location | 4 (17,4) |
Peripheral artery disease | 18 (78,3) | Previous amputation in current location of the ulcer | 5 (21,7) | ||
Varicose veins/venous thrombosis | 8 (34,8) | ||||
Other additional (from 1 to 4 comorbidities, average 2.1 disease) | 11 (47,8) |
